Loading clinical trials...
Loading clinical trials...
This is a prospective randomized controlled, open-labeled study to identify the efficacy of probucol in combination with valsartan in patients with Diabetes nephropathy. The reduction of urinary album...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Guangdong Provincial People's Hospital
NCT01209000 · Minimal Change Disease (MCD), Membranous Nephropathy, and more
NCT07581145 · Foot Ulcer Due to Type 2 Diabetes Mellitus
NCT07023406 · Type 2 Diabetes Mellitus (T2DM)
NCT05692388 · Diabetic Nephropathy Type 2 - Uncontrolled, Diabetes Mellitus, Type 2, and more
NCT06613854 · Type 2 Diabetes Mellitus (T2DM)
Guangdong General Hospital
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions